RxDoctor Payments Data

Edgar Sosa, DO

Plastic and Reconstructive Surgery · Vero Beach, FLNPI 1699938472

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $495,974 of the $503,653 with a category attached, or 98.5%. AbbVie accounts for 99.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $251,804 and has fallen 99.6% since, to $1,128 in 2025. Among plastic and reconstructive surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$503,653in general payments, 2019–2025

Across 179 payments — averaging $2813.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$499K
  • Sientra, Inc.$2K
  • Innovation Technologies Inc$743
  • Integra Lifesciences Corporation$698
  • Merz North America, Inc.$251
  • Motiva USA, LLC$155
  • plus $1K from 15 others

What the payments were for

  • Speaking & faculty fees$495,97498%
  • Travel & lodging$1760%
  • Food & beverage$7,5031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$503,653 in reported general payments places this provider in the 95th percentile of 235 plastic and reconstructive surgery providers in Florida.

See all plastic and reconstructive surgery providers in Florida

Medicare billing

Part B allowed, 2024
$16,349
Medicare patients
32
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin21$114

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Vero Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →